Authors


Joel M. Blau, CFP

Latest:

Preserve assets for heirs after second marriage

A relatively simple technique called the spousal lifetime access trust has proven especially advantageous and popular among those who have remarried and want to provide for children from a prior marriage.


Laird Harrison

Latest:

Sword, fire, ice offer options in small renal masses

Nephron-sparing procedures now have clear advantages over radical nephrectomy for most small renal masses.


Shandra Wilson, MD

Latest:

Using bisphosphonates to treat PCa-related bone events

Prostate cancer is the most prevalent non-cutaneous cancer diagnosed in men today, still accounting for a significant amount of morbidity and mortality in spite of increased screening efforts and advances in treatment.


E. David Crawford, MD

Latest:

Letter: Declassifying Gleason 6 as a cancer would do more harm than good

"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.


J. Brantley Thrasher, MD

Latest:

ABU makes changes to reduce burden during pandemic

"During these times of uncertainty, panic, and social distancing associated with COVID-19, the American Board of Urology is sensitive to the additional stress this pandemic has placed on urology practices and urologists’ ability to meet their certificate requirements," writes J. Brantley Thrasher, MD.


Fred Gebhart

Latest:

Comet assay may predict assisted reproductive techniques pregnancy success

There is a significant correlation between Comet assay results and the likelihood of pregnancy using ART.


Badrinath R. Konety

Latest:

Bladder cancer data must be taken in context

New bladder cancer data are food for thought, but are not conclusive proof that urologists are over-treating early-stage bladder cancer and running up costs.


Brian R. Matlaga, MD, MPH

Latest:

Study of stone pain stresses personalized treatment

"This work is important to our field, because it represents an effort to personalize treatment approaches to particular patients’ needs," writes Brian R. Matlaga, MD, MPH.


Scott MacDiarmid, MD

Latest:

PTNS for overactive bladder: Patient selection and technique

This article provides a real-world definition of refractory overactive bladder and its prevalence, then examines treatment options, with a focus on percutaneous tibial nerve stimulation as a noninvasive form of neuromodulation “for the masses.”


Mary Beth Nierengarten

Latest:

Partial nephrectomy shows increased survival benefit

A recently published population-based study reinforces prior evidence from retrospective studies of the increased survival benefit of partial nephrectomy over radical nephrectomy, and suggests a cancer-specific survival benefit for nephron-sparing approaches as well.


Ramakrishna Venkatesh, MD

Latest:

Recurrent stone disease: Steps for practical management

Between 30% and 60% of calcium oxalate stone patients have hypercalciuria in the absence of raised serum calcium levels.


Khalid Badwan, MD

Latest:

Recurrent stone disease: Steps for practical management

Between 30% and 60% of calcium oxalate stone patients have hypercalciuria in the absence of raised serum calcium levels.


Michael Cookson, MD

Latest:

Prostate cancer and CV risk: The heart of the matter

"Perhaps there is another Nobel Prize waiting to be had if we could reduce the cardiovascular effect of ADT and unlock the answer to the controversy surrounding the comparative safety and impact on cardiovascular health between GnRH agonists and antagonists," writes Michael S. Cookson, MD, MMHC.


Nicholas Mulcahy

Latest:

Delaying surgery safe in von Hippel-Lindau patients

San Francisco--Even though patients with von Hippel-Lindau disease are at risk for renal tumors and eventual metastatic RCC, parenchymal-sparing surgery can be delayed until the largest tumor reaches 3 cm with minimal concern that the patient will develop metastatic renal cell carcinoma, according to updated data from an ongoing National Institutes of Health study.


Jill C. Buckley, MD

Latest:

The male sling for SUI: Indications and techniques

The male sling achieves continence by unilateral ventral urethral compression that does not require patient activation, allowing volitional and spontaneous voiding.


Jack W. McAninch, MD

Latest:

The male sling for SUI: Indications and techniques

The male sling achieves continence by unilateral ventral urethral compression that does not require patient activation, allowing volitional and spontaneous voiding.


J. Brantley Thrasher, MD

Latest:

The BCG shortage: What's being done—and what you can do

In this interview, Seth P. Lerner, MD, discusses current recommendations for managing patients during the BCG shortage, what the FDA is doing to resolve the problem, and a SWOG trial testing a new strain of BCG.


Mark Painter

Latest:

How to bill for catheter placement in the hospital setting

In this "Coding Q&A" column, Ray Painter, MD, and Mark Painter also answer questions regarding bladder instillations and penile modeling during IPP placement.


Shlomo Raz, MD

Latest:

Urologists, GYNs demonstrate slings’ safety

"An abstract authored by Löppenberg et al is an interesting analysis of information from a respected prospective database examining variations in the quality of care provided to patients undergoing sling placement by gynecologists and urologists," write Seth A. Cohen, MD, and Shlomo Raz, MD.


Yair Lotan, MD

Latest:

Strategies to mitigate impact of intravenous ICM shortage

"The global shortage of ICM has necessitated rapid adaptation of workflows and clinical pathways, which are particularly important for practicing urologists who are evaluating patients for hematuria," write Yair Lotan, MD, and colleagues.


Glenn M. Preminger, MD

Latest:

Enhancements to PNL make a good procedure even better

The tubeless PNL approach provided the greatest comfort for the patient.


Marcelo A. Orvieto, MD

Latest:

Managing laparoscopic injuries: An addendum

This addendum includes advice on managing gas emboli/vascular insufflation,vascular injuries, subcutaneous emphysema, pneumomediastinum, and pneumothoraxArieh L. Shalhav, MD, is associate professor of surgery and directorof minimally invasive urology, and Marcelo A. Orvieto, MD, is a fellowin minimally invasive urology, University of Chicago.As discussed in a recent "Hands On" article ("How to preventand manage laparoscopic injuries," July 2003, page 50), the overallcomplication rate related to urologic laparoscopy is approximately 4%, varyingwidely according to the procedure's technical difficulty. In this addendumto the article, we discuss how urologists can prevent and manage additionalcomplications associated with laparoscopy, including gas emboli/vascularinsufflation, vascular injuries, subcutaneous emphysema, pneumomediastinum,and pneumothorax.


Steven A. Kaplan, MD

Latest:

LUTS’ burden may extend to cardiac events

"LUTS is an important health care burden, and health care professionals should be screening for its presence in men at risk," writes Steven A. Kaplan, MD.


Robert A. Nozar

Latest:

Urology avoids financial woes of other specialties

Minneapolis--Surgeons and other physicians across the country continueto deal with the higher costs of practicing medicine in the face of decliningreimbursements. Those factors added up to lower profit margins for U.S.physician groups in 2002 and a continuing awareness of the need to pay attentionto all of the vagaries of the business of practicing medicine. For the mostpart, urologists showed little change in reimbursement.


Lawrence M. Prescott, PhD

Latest:

COX-2 inhibitor exhibits anti-cancer effects in prostate cancer

Atlanta-Initial results with neoadjuvant celecoxib (Celebrex) strongly suggest that this may be a promising agent in the management of patients with early localized prostate cancer, British researchers reported at the American Society of Clinical Oncology annual meeting.


Paul F. Schellhammer, MD

Latest:

Bladder cancer studies help pinpoint risk of recurrence

Progression-free curves for N0 disease were improved when more than eight to 10 nodes per side were removed.


Andrew Bowser

Latest:

Pembro shows promising antitumor activity

Pembrolizumab (Keytruda) is showing encouraging antitumor activity in an ongoing phase II study including patients with high-risk, nonmuscle-invasive bladder cancer that is unresponsive to bacillus Calmette-Guérin treatment.


Caroline Helwick

Latest:

Sperm retrieval in NOA varicocele patients: Side matters

New Orleans-When retrieving sperm from men with nonobstructive azoospermia (NOA) and associated varicocele, go for the testis on the right side. That's the bottom line advice of University of California, San Francisco investigators who evaluated whether side matters in retrieving sperm for ICSI.


Scott Tennant

Latest:

Surgical developments take center stage in andrology

There will always be a place for laboratory research in andrology, but the past year has been one of surgical advancements for those who diagnose and treat male infertility.


Larry Prescott

Latest:

Can cystitis management be just a phone call away?

Chicago-Large-scale telephone-based management of eligible women withpresumed cystitis is associated with low clinical recurrence rates and avery low incidence of other gynecourologic diagnoses, according to a studyfrom a large California health maintenance organization.

© 2025 MJH Life Sciences

All rights reserved.